Generation of Transgene-Free Lung Disease-Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette  

Aba Somers(Boston University), Jyh‐Chang Jean(Boston University), Cesar Sommer(Boston University), Amel Omari(Boston University), Christopher C. Ford(Boston University), Jason A. Mills(Children's Hospital of Philadelphia), Lei Ying(Children's Hospital of Philadelphia), Andreia Gianotti Sommer(Boston University), Jenny M. Jean(Boston University), Brenden W. Smith(Boston University), Robert Lafyatis(Boston University), Marie‐France Demierre(Boston University), Daniel J. Weiss(University of Vermont), Deborah L. French(Children's Hospital of Philadelphia), Paul Gadue(Children's Hospital of Philadelphia), George J. Murphy(Boston University), Gustavo Mostoslavsky(Boston University), Darrell N. Kotton(Boston University)
Stem Cells
August 17, 2010
Cited by 424Open Access
Full Text

Abstract

The development of methods to achieve efficient reprogramming of human cells while avoiding the permanent presence of reprogramming transgenes represents a critical step toward the use of induced pluripotent stem cells (iPSC) for clinical purposes, such as disease modeling or reconstituting therapies. Although several methods exist for generating iPSC free of reprogramming transgenes from mouse cells or neonatal normal human tissues, a sufficiently efficient reprogramming system is still needed to achieve the widespread derivation of disease-specific iPSC from humans with inherited or degenerative diseases. Here, we report the use of a humanized version of a single lentiviral "stem cell cassette" vector to accomplish efficient reprogramming of normal or diseased skin fibroblasts obtained from humans of virtually any age. Simultaneous transfer of either three or four reprogramming factors into human target cells using this single vector allows derivation of human iPSC containing a single excisable viral integration that on removal generates human iPSC free of integrated transgenes. As a proof of principle, here we apply this strategy to generate >100 lung disease-specific iPSC lines from individuals with a variety of diseases affecting the epithelial, endothelial, or interstitial compartments of the lung, including cystic fibrosis, α-1 antitrypsin deficiency-related emphysema, scleroderma, and sickle-cell disease. Moreover, we demonstrate that human iPSC generated with this approach have the ability to robustly differentiate into definitive endoderm in vitro, the developmental precursor tissue of lung epithelia.


Related Papers

No related papers found

Powered by citation graph analysis